Clinical Trials in Latina, Italy
15 recruiting
Showing 1–20 of 22 trials
Recruiting
Phase 3
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Pfizer200 enrolled48 locationsNCT06616194
Recruiting
Phase 3
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting
Phase 3
Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
Migraine
AbbVie1,300 enrolled149 locationsNCT06241313
Recruiting
Phase 2Phase 3
Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study
STEMI (ST Elevation MI)
Federico II University100 enrolled3 locationsNCT07380919
Recruiting
Phase 3
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Menstrual Migraine (MM)
AbbVie430 enrolled95 locationsNCT06806293
Recruiting
Observational Study on Lutetium (177Lu) Vipivotide Tetraxetan to Treat Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Novartis Pharmaceuticals300 enrolled32 locationsNCT07093801
Recruiting
Phase 1Phase 2
Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients
Relapsed or Refractory Hodgkin's Lymphoma
Fondazione Italiana Linfomi - ETS122 enrolled32 locationsNCT05300282
Recruiting
Phase 4
INSIGHTFUL-FFR Clinical Trial
Acute Coronary SyndromeCoronary Artery Disease
CoreAalst BV2,500 enrolled29 locationsNCT05437900
Recruiting
Phase 3
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS190 enrolled48 locationsNCT05929222
Recruiting
Phase 3
Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
Marginal Zone Lymphoma
The Lymphoma Academic Research Organisation260 enrolled48 locationsNCT06006117
Recruiting
Vitamin k, D-chiro Inositol and α-lactalbumin in Bone Homeostasis
Breast Cancer FemalesOsteoporosis Secondary
Regina Elena Cancer Institute134 enrolled2 locationsNCT07256769
Recruiting
BRCA Mutation Carriers' Platform a Multicenter Study
BRCA1 MutationBRCA2 Mutation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS10,000 enrolled40 locationsNCT07253051
Recruiting
Prevention ICONA Dedicated Ensemble
HIV-1-infectionHIVPrEP+3 more
Fondazione ICONA5,000 enrolled53 locationsNCT07186244
Recruiting
Not Applicable
Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
Coronary DiseaseCoronary Artery DiseaseIschemic Heart Disease
Centro per la Lotta Contro l'Infarto - Fondazione Onlus1,420 enrolled34 locationsNCT05027984
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
VEXAS SyndromeCastleman DiseaseUveitis+8 more
University of Siena3,500 enrolled112 locationsNCT05200715
Recruiting
Phase 3
Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)
High-risk MDS
Gruppo Italiano Malattie EMatologiche dell'Adulto274 enrolled46 locationsNCT04184505
Recruiting
Not Applicable
Wide-Antral Pulmonary Vein Isolation in Atrial Fibrillation Ablation with a Single-shot Technique (WIDER-PVI)
Atrial FibrillationAtrial Fibrillation (Paroxysmal)
Hospital Universitario 12 de Octubre440 enrolled17 locationsNCT06698159
Recruiting
Onset of Sensory Block After Thoracic ESP Block
Breast Cancer SurgeryESPB
Ospedale Santa Maria Goretti30 enrolled1 locationNCT06642142
Recruiting
Phase 3
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Acute Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto414 enrolled48 locationsNCT04168502
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
X-linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd1,343 enrolled118 locationsNCT03193476